ConferenceSeries offers One-of-A-Kind Experience with On-Site and Online Scientific Conferences

Food and Healthcare Press Releases Friday July 20, 2018 11:47
LONDON--20 Jul--PRNewswire/InfoQuest
Event organizer bringing its 10 years of healthcare communication expertise and deep knowledge of research to the scientific community

ConferenceSeries is a medical and life sciences event organiser engaged in 'Healthcare Communication' for over a decade through a series of scientific conferences across Europe, Asia and America. The uniqueness of the ConferenceSeries lies in its ability to collaborate with renowned scientific agencies within America and abroad and form ties with scientific societies to organize Medical Conferences,   Pharmaceutical Conferences, Life Science Conferences and Engineering Conferences.

Established with a view to organize independent medical meetings, ConferenceSeries serves a vast business and academic clientele base that includes organizations indulged in medical science   research, clinical practices and the pharmaceutical industry. ConferenceSeries could completely transform the traditional role of the scientific conference organizer that allowed interaction among the participants who are physically attending it. Effective from 2019 ConferenceSeries also offers Online scientific events in association with its partnered companies on 50+ different disciplines, said Dr. Srinubabu Gedela ,   CEO, Omics International .

All major meetings of ConferenceSeries are accredited with Continued Professional Education (CPD), Continued Education (CE), and Continued Medical Education (CME) Credits . ConferenceSeries takes the stand of a legitimate body, vested with the responsibility of assessing the scientific content and assures its quality as per the accepted standards. ConferenceSeries encourages the early stage academicians and researchers to be part of the Young Research Forum, Best Poster Competition and E-Poster to collaborate for effective partnering, interaction with fellow young researchers and senior researchers and guidance on career prospects, fostering transcontinental cooperation, mutual agreement and engagement among young researchers. Its events help to gain visibility in the global context.

ConferenceSeries is a crucial player in organizing 2000+ International Conferences annually in over twenty European Countries (UK, Germany, Spain, Italy, Ireland, Netherlands, Belgium, France, Austria, Portugal, Czech Republic etc.) in some of the top most conference destinations (London, Rome, Berlin, Madrid, Barcelona, Amsterdam, Brussels, Paris, Vienna, Lisbon, Prague, etc.). ConferenceSeries is partnered with Omics International to conduct conferences and publish proceedings. It focuses on a wide array of subjects such as: Agriculture, Biochemistry, Cardiology, Chemical Engineering, Chemistry, Dentistry, Diabetes, Engineering, Environmental Sciences, Food, Gastroenterology, Genetics, Geology-Earth Science, Healthcare, Immunology, Infectious Diseases, Materials Science, Microbiology, Nanotechnology, Nephrology, Neuroscience, Nursing, Nutrition, Oncology, Ophthalmology, Pediatrics, Pharmaceutical Sciences, Surgery, Vaccines and Veterinary among many others.

Contact :+1 6508894686 email:
Logo -

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(

Related Topics